The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Treatment of Phobias: I. Comparison of Imipramine Hydrochloride and Placebo
Abstract
In a controlled-outcome study of phobias, 218 adult phobic patients (147 women and 71 men) received a course of 26 weekly treatment sessions that consisted of behavior therapy (BT) and imipramine hydrochloride, BT and placebo, or supportive psychotherapy and imipramine. The BT consisted of systematic desentization using fantasy and assertiveness training. Patients were classified as agoraphobic, mixed phobic, or simple phobic. Although the conditions of most patients in each group showed moderate to marked improvement, the effects of imipramine were significantly superior to those of placebo in patients with spontaneous panic attacks, ie, patients with agoraphobia or mixed phobia. In patients with simple phobia, who do not experience spontaneous panic, there was not a significant difference between imipramine and placebo. This study clearly distinguished those phobic patients who experienced spontaneous panic from those who did not in terms of pharmacologic benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1969) · Cited by 18,340
Delineation of two drug-responsive anxiety syndromes
Klein, D. F. (1964) · Psychopharmacologia · doi:10.1007/bf02193476 · Cited by 898
Self-citationTreatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal Symptoms
Sheehan, D. V. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140053006 · Cited by 729
PSYCHIATRIC REACTION PATTERNS TO IMIPRAMINE
KLEIN, D. F., & FINK, M. (1962) · American Journal of Psychiatry · doi:10.1176/ajp.119.5.432 · Cited by 416
Concerning least squares analysis of experimental data.
Overall, J. E., & Spiegel, D. K. (1969) · Psychological Bulletin · doi:10.1037/h0028109 · Cited by 394
Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine
Zitrin, C. M. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140065007 · Cited by 332
Self-citationControlled Imipramine Treatment of School Phobia
Gittelman-Klein, R. (1971) · Archives of General Psychiatry · doi:10.1001/archpsyc.1971.01750150012002 · Cited by 276
Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects
KLEIN, D. F. (1967) · Archives of General Psychiatry · doi:10.1001/archpsyc.1967.01730190120016 · Cited by 276
Behavior Therapy, Supportive Psychotherapy, Imipramine, and Phobias
Zitrin, C. M. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770270057005 · Cited by 246
Self-citationMarks, I. M. (1978) · Cited by 136
Cited by
Clark, D. M. (1986) · Behaviour Research and Therapy · doi:10.1016/0005-7967(86)90011-2 · Cited by 2,422
Chambless, D. L., Caputo, G. C., Bright, P., & Gallagher, R. (1984) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.52.6.1090 · Cited by 1,247
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Charney, D. S. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190025003 · Cited by 599
Social Phobia: Review of a Neglected Anxiety Disorder
Liebowitz, M. R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790300097013 · Cited by 577
Ballenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Leichsenring, F., Rabung, S., & Leibing, E. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.12.1208 · Cited by 538
Charney, D. S., Woods, S. W., Goodman, W. K., & Heninger, G. R. (1987) · Psychopharmacology · doi:10.1007/bf00215473 · Cited by 462
Increased Anxiogenic Effects of Caffeine in Panic Disorders
Charney, D. S. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260027003 · Cited by 428
Lactate Provocation of Panic Attacks: I. Clinical and Behavioral Findings
Liebowitz, M. R. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190038004 · Cited by 397
Mitte, K. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.05.003 · Cited by 396
Major Depression in Patients With Agoraphobia and Panic Disorder
Breier, A. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790230015002 · Cited by 317
Agoraphobia With Panic Attacks: Development, Diagnostic Stability, and Course of Illness
Breier, A. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800110015003 · Cited by 304
Charney, D. S. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800110028005 · Cited by 299
Kahn, R. J. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800010081010 · Cited by 278
Woods, S. W. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250051007 · Cited by 265
Adrenergic Function in Patients With Panic Anxiety
Nesse, R. M. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190045005 · Cited by 260
Andrews, G., Bell, C., Boyce, P., Gale, C., Lampe, L., Marwat, O., Rapee, R., & Wilkins, G. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418799453 · Cited by 243
Pecknold, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290043006 · Cited by 204
Social anxiety disorder in childhood and adolescence: Current status and future directions
Kashdan, T. B., & Herbert, J. D. (2001) · Clinical Child and Family Psychology Review · doi:10.1023/a:1009576610507 · Cited by 205
Bandelow, B., Seidler-Brandler, U., Becker, A., Wedekind, D., & Rüther, E. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970601110273 · Cited by 166
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.683 · Cited by 144
Schweizer, E. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130053009 · Cited by 120
Phobia: prevalence and risk factors
Boyd, J. H., Rae, D. S., Thompson, J. W., Burns, B. J., Bourdon, K., Locke, B. Z., & Regier, D. A. (1990) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00782887 · Cited by 112
The evidence-based pharmacotherapy of social anxiety disorder
Blanco, C., Bragdon, L. B., Schneier, F. R., & Liebowitz, M. R. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000119 · Cited by 99
Krystal, J. H., Woods, S. W., Hill, C. L., & Charney, D. S. (1991) · Comprehensive Psychiatry · doi:10.1016/0010-440x(91)90026-9 · Cited by 73
A case of panic disorder treated with breathing retraining
Rapee, R. M. (1985) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(85)90032-1 · Cited by 61
Treatment-Resistant Panic Disorder
Bandelow, B., & Rüther, E. (2004) · CNS Spectrums · doi:10.1017/s1092852900022379 · Cited by 57
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder
Chouinard, G., Saxena, B., Bélanger, M.-C., Ravindran, A., Bakish, D., Beauclair, L., Morris, P., Vasavan Nair, N. P., Manchanda, R., Reesal, R., et al. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00188-8 · Cited by 57
Panic Disorder and Chest Pain: Mechanisms, Morbidity, and Management
Huffman, J. C., Pollack, M. H., & Stern, T. A. (2002) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v04n0203 · Cited by 35
A Guide to Benzodiazepine Selection. Part II: Clinical Aspects
Teboul, E., & Chouinard, G. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600117 · Cited by 25
Long-term drug treatment of panic disorder
Burrows, G. D., Judd, F. K., & Norman, T. R. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90022-t · Cited by 19
Psychopharmacology for Social Anxiety Disorder
Blanco, C., Bragdon, L., Schneier, F. R., & Liebowitz, M. R. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00022-4 · Cited by 2
Metadata
- Authors
- Zitrin, C. M.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1983-02-01
- Volume
- 40
- Issue
- 2
- Pages
- 125
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W1997745753
- Cited by
- 342
- References
- 14
- FWCI
- 45.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.